|
Number
|
86
|
77
|
|
Age (years [mean ± SD])
|
60.7 ± 12.9
|
63.6 ± 11.9
|
|
Rheumatoid Factor (% positive)
|
70.9%
|
64.9%
|
|
Sex (% female)
|
86.0%
|
79.2%
|
|
Disease duration (years [mean ± SD]; oMTX/rMTX)
|
9.5 ± 8.3/13.3 ± 8.6
|
7.5 ± 8.5/12.6 ± 8.6
|
|
Prior DMARDs (median [range]; oMTX/rMTX)
|
1 (0–6)/4 (2–9)
|
1 (0–8)/3 (2–10)
|
|
Baseline dose (mg/week [median (1st-3rd quartile)]; oMTX/rMTX)
|
10.0 (7.5–15.0)/15.0 (10.0–20.0)
|
-/-
|
|
Base line CRP (mg/l [mean ± SD]; oMTX/rMTX)
|
33.4 ± 26.2/29.1 ± 31.0
|
15.2 ± 16.8/18.3 ± 23.0
|
|
Base line ESR (mm/hour [mean ± SD]; oMTX/rMTX)
|
47.0 ± 30.0/35.0 ± 22.0
|
30 ± 13/32 ± 22
|
